Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polyna Khudyakov

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Lancet. Diabetes & Endocrinology|December 4, 2023
Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trialDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Influence of vitamin D supplementation on fracture risk, bone mineral density and bone biochemistry in Mongolian schoolchildren: multicenter double-blind randomized placebo-controlled trialDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2018
Prevalence and Determinants of QuantiFERON-Diagnosed Tuberculosis Infection in 9810 Mongolian SchoolchildrenDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Psychopharmacology|August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trialPeter C T Hawkins, Adam J Schwarz, James M Stone, et al.
JAMA Neurology|January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical TrialNiraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.
The New England Journal of Medicine|July 25, 2020
Vitamin D Supplements for Prevention of Tuberculosis Infection and DiseaseDavaasambuu Ganmaa, Buyanjargal Uyanga, Xin Zhou, et al.
The Journal of Nutrition|March 13, 2026
A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The Vitamin D for COVID-19 TrialDavaasambuu Ganmaa, Kaitlyn A Cook, Polyna Khudyakov, et al.
European Journal of Preventive Cardiology|April 7, 2020
The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic riskDonna Spiegelman, Laura C Lovato, Polyna Khudyakov, et al.
The American Journal of Clinical Nutrition|January 27, 2012
Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studiesXuehong Zhang, Donna Spiegelman, Laura Baglietto, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Lancet. Diabetes & Endocrinology|December 4, 2023
Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trialDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Influence of vitamin D supplementation on fracture risk, bone mineral density and bone biochemistry in Mongolian schoolchildren: multicenter double-blind randomized placebo-controlled trialDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2018
Prevalence and Determinants of QuantiFERON-Diagnosed Tuberculosis Infection in 9810 Mongolian SchoolchildrenDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Psychopharmacology|August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trialPeter C T Hawkins, Adam J Schwarz, James M Stone, et al.
JAMA Neurology|January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical TrialNiraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.
The New England Journal of Medicine|July 25, 2020
Vitamin D Supplements for Prevention of Tuberculosis Infection and DiseaseDavaasambuu Ganmaa, Buyanjargal Uyanga, Xin Zhou, et al.
The Journal of Nutrition|March 13, 2026
A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The Vitamin D for COVID-19 TrialDavaasambuu Ganmaa, Kaitlyn A Cook, Polyna Khudyakov, et al.
European Journal of Preventive Cardiology|April 7, 2020
The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic riskDonna Spiegelman, Laura C Lovato, Polyna Khudyakov, et al.
The American Journal of Clinical Nutrition|January 27, 2012
Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studiesXuehong Zhang, Donna Spiegelman, Laura Baglietto, et al.
Pageof 3